Pure Global

LEICA BIOSYSTEMS NEWCASTLE LTD - Medical Device Manufacturer in Indonesia

LEICA BIOSYSTEMS NEWCASTLE LTD from United Kingdom is a medical device manufacturer with 20 registered products in the Indonesia BPOM database through Pure Global AI's free platform. The company produces 20 unique product types across 2 product classes.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.

Free Manufacturer Profile
Powered by Pure Global AI
20 Products
2 Classes
🇮🇩
LEICA BIOSYSTEMS NEWCASTLE LTD
United Kingdom
20
Total Products
20
Product Names
2
Product Classes
2
Risk Classes
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Risk Classification Breakdown
Distribution of products across risk classes
Kelas Resiko : A
12 products
60.0%
Kelas Resiko : B
8 products
40.0%
Recent Registrations (20 most recent)
Most recently registered products with BPOM

LEICA Novocastra ™ Liquid Mouse Monoclonal Antibody Inhibin Alpha

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Feb 10, 2025

LEICA BOND™ Multi-Cytokeratin (AE1/AE3)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 25, 2023

LEICA BOND™ Ready-to-Use Primary Antibody PMS2 (Mismatch Repair Protein) (EP51)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 10, 2023

LEICA BOND™ Ready-to-Use Primary Antibody MSH2 (Mismatch Repair Protein) (79H11)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 9, 2023

LEICA BOND™ Ready-to-Use Primary Antibody MLH1 (Mismatch Repair Protein) (ES05)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 8, 2023

LEICA Novocastra Liquid Mouse Monoclonal Antibody CD21

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 6, 2023

LEICA BOND™ Ready-to-Use Primary Antibody MSH6 (Mismatch Repair Protein) (EP49)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 6, 2023

LEICA BOND Ready-to-Use Primary Antibody CD30 (JCM182)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 4, 2023

LEICA BOND Oracle HER2 IHC System

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Oct 4, 2023

LEICA BOND Ready-to-Use Primary Antibody Synaptophysin (27G12)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Sep 29, 2023

LEICA BOND Ready-to-Use Primary Antibody Terminal Deoxynucleotidyl Transferase (SEN28)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 29, 2023

LEICA BOND Ready-to-Use Primary Antibody Myosin Heavy Chain (smooth muscle) (S131)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 29, 2023

LEICA BOND ™ Ready-to-Use Primary Antibody Melan A (A103)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 26, 2023

LEICA BOND™ Ready-to-Use Primary Antibody CD15 (MMA)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Sep 25, 2023

LEICA BOND™ Ready-to-Use Primary Antibody Alpha-Methylacyl-CoA Racemase (EPMU1)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 25, 2023

LEICA BOND Ready-to-Use Primary Antibody E-Cadherin (36B5)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 25, 2023

LEICA BOND™ Ready-to-Use Primary Antibody CD31 (JC70A)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 25, 2023

LEICA BOND™ Ready-to-Use Primary Antibody Muscle Specific Actin (HHF35)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 22, 2023

LEICA BOND™ Ready-to-Use Primary Antibody Cytokeratin (AE1/AE3)

Class:

Kelas : 2

Risk Class:
Kelas Resiko : B
Registration Date:

Sep 22, 2023

LEICA BOND Ready-To-Use Primary Antibody Myf-4 (Rhabdomyosarcoma Marker) (L026)

Class:

Kelas : 1

Risk Class:
Kelas Resiko : A
Registration Date:

Sep 22, 2023